Published in Nanotoxicology on February 10, 2011
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol (2013) 1.30
In vivo integrity of polymer-coated gold nanoparticles. Nat Nanotechnol (2015) 1.08
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
Nanoparticles for brain drug delivery. ISRN Biochem (2013) 0.99
Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol (2013) 0.98
Silver and gold nanoparticles exposure to in vitro cultured retina--studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity. PLoS One (2014) 0.90
Gold- and silver nanoparticles affect the growth characteristics of human embryonic neural precursor cells. PLoS One (2013) 0.86
In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine (2013) 0.85
In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J Nanotechnol (2014) 0.83
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood-brain barrier using Evans blue and TEM. Int J Nanomedicine (2014) 0.79
Influence of gold, silver and gold-silver alloy nanoparticles on germ cell function and embryo development. Beilstein J Nanotechnol (2015) 0.79
Traffic-related air pollution and brain development. AIMS Environ Sci (2015) 0.78
Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat. Part Fibre Toxicol (2014) 0.78
Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model. Environ Health Perspect (2015) 0.77
Oral absorption of PEG-coated versus uncoated gold nanospheres: does agglomeration matter? Part Fibre Toxicol (2015) 0.77
Applied Nanotoxicology. Int J Toxicol (2016) 0.75
Influence of dendritic polyglycerol sulfates on knee osteoarthritis: an experimental study in the rat osteoarthritis model. BMC Musculoskelet Disord (2015) 0.75
Synthesis of Gold Nanoparticles with Buffer-Dependent Variations of Size and Morphology in Biological Buffers. Nanoscale Res Lett (2016) 0.75
A comparison between sphere and rod nanoparticles regarding their in vivo biological behavior and pharmacokinetics. Sci Rep (2017) 0.75
Acute hematologic, hepatologic, and nephrologic changes after intraperitoneal injections of 18 nm gold nanoparticles in hamsters. Int J Nanomedicine (2016) 0.75
Size Effects on the Interaction of QDs with the Mitochondrial Membrane In Vitro. J Membr Biol (2016) 0.75
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development (1990) 8.37
Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small (2005) 6.90
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Size-dependent cytotoxicity of gold nanoparticles. Small (2007) 4.10
Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect (2005) 3.57
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials (2010) 3.54
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Biological applications of gold nanoparticles. Chem Soc Rev (2008) 3.01
Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol (1990) 2.45
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (2009) 2.20
Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci (2001) 2.09
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release (2006) 2.05
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine (2008) 1.99
Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir (2004) 1.86
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials (2009) 1.82
Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. Langmuir (2004) 1.80
Interaction of gold nanoparticles with common human blood proteins. ACS Nano (2010) 1.74
The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett (2009) 1.71
M cells in Peyer's patches of the intestine. Int Rev Cytol (1996) 1.47
The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol (1989) 1.46
In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces (2008) 1.42
Rapid insorption of small particles in the gut. Am J Gastroenterol (1990) 1.37
Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm Res (2006) 1.37
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun (2010) 1.27
Nanosystem drug targeting: Facing up to complex realities. J Control Release (2009) 1.26
Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci (2005) 1.16
PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm Res (2009) 1.11
The relevance of shape and size of Au55 clusters. Chem Soc Rev (2008) 1.03
Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J Drug Target (1995) 1.00
Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J Drug Target (1994) 0.98
A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm (2010) 0.97
Effects of isoflurane on gastrointestinal motility after brief exposure in rats. Int J Pharm (2005) 0.96
Uptake and presentation of orally administered antigens. Vaccine (2005) 0.95
Cytochrome C on silica nanoparticles: influence of nanoparticle size on protein structure, stability, and activity. Small (2009) 0.93
Biliary excretion of polystyrene microspheres with covalently linked FITC fluorescence after oral and parenteral administration to male Wistar rats. J Drug Target (1996) 0.93
Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release (2000) 0.92
Reaction of Au(55)(PPh(3))(12)Cl(6) with thiols yields thiolate monolayer protected Au(75) clusters. J Am Chem Soc (2005) 0.92
Increasing protein stability through control of the nanoscale environment. Langmuir (2006) 0.92
Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles. Pharm Res (1998) 0.92
Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models. Inhal Toxicol (2009) 0.86
[Blood volume of rat organs and residual amount of blood after blood letting or irrigation; determination with radiophosphorus-labeled erythrocytes]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1955) 0.86
Uptake of inert microparticles in normal and immune deficient mice. Int J Pharm (2007) 0.85
Pharmaceutical nanotechnology: more than size. Ten topics for research. Int J Pharm (2007) 0.84
Factors influencing intestinal microparticle uptake in vivo. Int J Pharm (2006) 0.82
The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles. Biomaterials (2007) 0.81
Intestinal absorption of macromolecules and small particles. Dig Dis (1990) 0.81
On the size evolution of gold-monolayer-protected clusters by ligand place-exchange reactions: the effect of headgroup-gold interactions. Langmuir (2010) 0.80
The influence of age and particle number on absorption of polystyrene particles from the rat gut. J Anat (1996) 0.80
Size-dependent cytotoxicity of gold nanoparticles. Small (2007) 4.10
Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol (2010) 2.85
Metal and metal oxide nanoparticles in chemiresistors: does the nanoscale matter? Small (2006) 2.72
Biodistribution of 1.4- and 18-nm gold particles in rats. Small (2008) 2.32
Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol (2010) 2.27
Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small (2009) 2.20
Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med (2007) 1.83
Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol (2009) 1.78
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
Effects of particulate air pollution on blood pressure and heart rate in subjects with cardiovascular disease: a multicenter approach. Environ Health Perspect (2004) 1.70
Ultrafine particle-lung interactions: does size matter? J Aerosol Med (2006) 1.69
Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65
The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol (2007) 1.56
Health effects of particles in ambient air. Int J Hyg Environ Health (2004) 1.55
Upper Palaeolithic infant burials. Nature (2006) 1.55
Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung. Eur J Pharm Biopharm (2010) 1.49
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Expert elicitation on ultrafine particles: likelihood of health effects and causal pathways. Part Fibre Toxicol (2009) 1.35
Prediction of fracture callus mechanical properties using micro-CT images and voxel-based finite element analysis. Bone (2005) 1.33
Low-voltage organic transistors with an amorphous molecular gate dielectric. Nature (2004) 1.31
Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm (2010) 1.29
Solvate-supported proton transport in zeolites. Chemphyschem (2004) 1.29
Cellular uptake and toxicity of Au55 clusters. Small (2005) 1.23
Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone. Osteoporos Int (2004) 1.20
Zeolites as nanoporous, gas-sensitive materials for in situ monitoring of DeNO(x)-SCR. Beilstein J Nanotechnol (2012) 1.19
Changes in strain distribution of loaded proximal femora caused by different types of cementless femoral stems. Clin Biomech (Bristol, Avon) (2006) 1.18
Nanoparticles in the lung. Nat Biotechnol (2010) 1.14
Concentration response functions for ultrafine particles and all-cause mortality and hospital admissions: results of a European expert panel elicitation. Environ Sci Technol (2010) 1.12
Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc Chem Res (2012) 1.10
Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol Appl Pharmacol (2009) 1.09
Application of a new calibration method for a three-dimensional finite element model of a human lumbar annulus fibrosus. Clin Biomech (Bristol, Avon) (2006) 1.07
Intradiscal pressure, shear strain, and fiber strain in the intervertebral disc under combined loading. Spine (Phila Pa 1976) (2007) 1.03
Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano (2013) 1.03
No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol (2006) 1.03
Internal loads in the human tibia during gait. Clin Biomech (Bristol, Avon) (2009) 1.00
Nanoparticle delivery in infant lungs. Proc Natl Acad Sci U S A (2012) 0.98
Postnatal lung function in the developing rat. J Appl Physiol (1985) (2008) 0.97
Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv (2013) 0.96
The effect of primary particle size on biodistribution of inhaled gold nano-agglomerates. Biomaterials (2013) 0.95
Trabecular bone fracture healing simulation with finite element analysis and fuzzy logic. J Biomech (2005) 0.95
Mechanical characterization of external fixator stiffness for a rat femoral fracture model. J Orthop Res (2009) 0.94
Rainforest air-conditioning: the moderating influence of epiphytes on the microclimate in tropical tree crowns. Int J Biometeorol (2002) 0.94
A novel model to study metaphyseal bone healing under defined biomechanical conditions. Arch Orthop Trauma Surg (2008) 0.94
Reversible photothermal melting of DNA in DNA-gold-nanoparticle networks. Small (2008) 0.94
Relationship between different size classes of particulate matter and meteorology in three European cities. J Environ Monit (2005) 0.93
Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit Rev Toxicol (2012) 0.92
Biodistribution of inhaled gold nanoparticles in mice and the influence of surfactant protein D. J Aerosol Med Pulm Drug Deliv (2012) 0.91
Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology. Health Phys (2015) 0.91
Left-to-right asymmetry of aerosol deposition after shallow bolus inhalation depends on lung ventilation. J Aerosol Med Pulm Drug Deliv (2009) 0.89
Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles. Nanotechnology (2013) 0.89
The influence of pulmonary surfactant on nanoparticulate drug delivery systems. Eur J Pharm Biopharm (2010) 0.89
Maintenance of bone mineral density after implantation of a femoral neck hip prosthesis. BMC Musculoskelet Disord (2008) 0.88
Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol (2013) 0.88
Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires. Angew Chem Int Ed Engl (2003) 0.88
Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium. Part Fibre Toxicol (2005) 0.88
Size-dependent multispectral photoacoustic response of solid and hollow gold nanoparticles. Nanotechnology (2012) 0.88
Influence of the fixation stability on the healing time--a numerical study of a patient-specific fracture healing process. Clin Biomech (Bristol, Avon) (2010) 0.88
On the application potential of gold nanoparticles in nanoelectronics and biomedicine. Philos Trans A Math Phys Eng Sci (2010) 0.87
High-sensitivity real-time analysis of nanoparticle toxicity in green fluorescent protein-expressing zebrafish. Small (2012) 0.87
Interfragmentary movement in diaphyseal tibia fractures fixed with locked intramedullary nails. J Orthop Trauma (2008) 0.87
Molecularly stabilised ultrasmall gold nanoparticles: synthesis, characterization and bioactivity. Nanoscale (2013) 0.86
Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive rats. Part Fibre Toxicol (2008) 0.86
Internal forces and moments in the femur of the rat during gait. J Biomech (2010) 0.86
Chain-like assembly of gold nanoparticles on artificial DNA templates via 'click chemistry'. Chem Commun (Camb) (2007) 0.86
The influence of hydrogen peroxide and histamine on lung permeability and translocation of iridium nanoparticles in the isolated perfused rat lung. Part Fibre Toxicol (2005) 0.85
Bifunctional DNA-gold nanoparticle conjugates as building blocks for the self-assembly of cross-linked particle layers. Biochem Biophys Res Commun (2003) 0.85
In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay. J Mater Chem B Mater Biol Med (2013) 0.85
Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci (2012) 0.85
Control of cell adhesion and neurite outgrowth by patterned gold nanoparticles with tunable attractive or repulsive surface properties. Small (2012) 0.85
Assembly of DNA-functionalized gold nanoparticles studied by UV/Vis-spectroscopy and dynamic light scattering. Phys Chem Chem Phys (2008) 0.85